Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

SEC Filing · SCHEDULE 13G/A

SCPHARMACEUTICALS INC

SEC Filing

Filed Feb 11, 2026Accepted Feb 11, 2026, 10:06 AM ESTCIK 1604950Accession 0001357550-26-000003
Share

Company context

Historical securities (1)

Recent company filings

  1. EFFECT filingNov 19, 2025
  2. EFFECT filingNov 19, 2025
  3. EFFECT filingNov 19, 2025
  4. SCHEDULE 13G - filed by Weiss Asset Management LP regarding scPharmaceuticals Inc.Nov 12, 2025
  5. 15-12G filingOct 17, 2025

Document unavailable

This filing is not currently available in the archive. Read it on SEC EDGAR ↗